Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Monojitketan Mukhopadhyay"'
Autor:
A.P.S. Kong, Chun-Chung Chow, Weiping Jia, K.-H. Yoon, Andrea O.Y. Luk, Juliana C.N. Chan, Jianping Weng, W.B. Chan, R M Toledo, Xue Li, Leorino Sobrepena, Y Zhang, Risa Ozaki, M Duran, Wing-Yee So, Wenhui Li, Eun Gyoung Hong, T K Nguyen, C C Tsang, Wayne H-H Sheu, Monojitketan Mukhopadhyay, Peter C.Y. Tong, T Q Do, Ronald C.W. Ma, A K Ojha, Wenying Yang, Xiaohu Guo
Publikováno v:
Diabetic Medicine. 33:1230-1239
Aims Diabetic kidney disease independently predicts cardiovascular disease and premature death. We examined the burden of chronic kidney disease (CKD, defined as an estimated GFR < 60 ml/min/1.73 m2) and quality of care in a cross-sectional survey of
Autor:
Wenhui Li, Xiaohui Guo, Wayne Huey-Herng Sheu, Wenying Yang, Wing-Yee So, Gary Ko, Ronaldo M Toledo, Winnie W. Y. Lau, Chiu Chi Tsang, Jianping Weng, Soon Jib Yoo, Trung Quan Do, Nicola Brown, Risa Ozaki, Leorino Sobrepena, Thy Khue Nguyen, Peter C.Y. Tong, Ronald C.W. Ma, G. E. Tutino, Arvind Kumar Ojha, Yu Cheung, Chaicharn Deerochanawong, Weiping Jia, W.B. Chan, Troels Wolthers, Kun-Ho Yoon, Mercedes Reyes-dela Rosa, Lee-Ming Chuang, C. C. Chow, Su-Yen Goh, Linong Ji, Rongwen Bian, Roseanne O. Yeung, Larry L.T. Ho, Sosale Ramachandra Aravind, Thep Himathongkam, Juliana C.N. Chan, Andrea O.Y. Luk, Eun Gyoung Hong, Alice P. Kong, Monojitketan Mukhopadhyay, Shaibal Chakraborty, Greg Lyubomirsky, Yuying Zhang
Publikováno v:
The Lancet Diabetes & Endocrinology. 2:935-943
The prevalence of diabetes is increasing in young adults in Asia, but little is known about metabolic control or the burden of associated complications in this population. We assessed the prevalence of young-onset versus late-onset type 2 diabetes, a
Autor:
Jothydev Kesavadev, Wayne Huey-Herng Sheu, Andrea O.Y. Luk, Thy Khue Nguyen, Chiu Chi Tsang, Hari Janakiraman, Sosale Ramachandra Aravind, Monojitketan Mukhopadhyay, Amy W C Fu, Quang Khanh Tran, Risa Ozaki, Roberto Mirasol, Linsey Gani, Sanjeev Phatak, Leorino Sobrepena, Sujeet Jha, Juliana C.N. Chan, Christine M. L. Kwan, Yoon Kun Ho, Wing-Yee So, Weiping Jia, Weinan Yu, Kanakatte Mylariah Prasanna Kumar, Eric S.H. Lau
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Biosimilar insulin can reduce treatment costs, although the extent of its use is largely unknown. We examined biosimilar insulin use and its associations with the quality of glycemic control using the Joint Asia Diabetes Evaluation